Ticker Symbol: TMDX
Transmedics Group Inc
$24.74 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001756262
Company Profile
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung and liver failure.
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3845
Address: 200 Minuteman Road
Website: www.transmedics.com
CEO: Waleed H. Hassanein
Tags:
- Medical Specialties
- Health Technology
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $51.67
Change:
-$1.11
(
-2.10%)
Days Range: $51.60 - $53.18
Beta: 1.52
52wk. High: $99.63
52wk. Low: $40.60
Ytd. Change -16.59%
50 Day Moving Average: $53.35
200 Day Moving Average: $71.25
Shares Outstanding: 32600000
Valuation
Market Cap: 168.4B
PE Ratio: -92.32
EPS (TTM): -0.5597
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A